COc1ccc2c3c1O[C@H]1C(O)CCC4(O)[C@@H](C2)NCC[C@]314
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?